EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TERT drives liver tumorigenesis beyond telomere elongation

Laura Braud iD, Julien Vernerey iD, Arnaud Guille, Pierre Cordier, Clémence Ginet, Tom Egger, Manuel Bernabe, Dmitri Churikov iD, Quentin Da Costa iD, Aïda Meghraoui, Chantal Desdouets iD, Li Gu und 3 weitere

Life Science Alliance · 2026-09 · 9 (9) · e202603660

DOI: 10.26508/lsa.202603660 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 02.07.2026. Verfasst von Laura Braud und 14 weiteren Autor:innen. Beteiligte Einrichtung: CRCM, Inserm, CNRS, Institut Paoli-Calmettes, Aix-Marseille University Marseille, Équipe labellisée par la Ligue Nationale Contre le Cancer, Marseill…. Hauptthemen laut MEDLINE: Telomerase, Liver Neoplasms, Carcinogenesis, Carcinoma, Hepatocellular. Die Arbeit nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We generated two mouse models, p21 +/Tert and p21 +/TertCi , expressing either telomerase reverse transcriptase (Tert) or a catalytically inactive variant under the control of the p21 promoter. By 18–20 mo of age, ∼15% of mice from both genotypes developed liver tumors with histopathological features resembling human hepatocellular carcinoma (HCC). Whole-exome sequencing identified activating Ctnnb1 mutations and recurrent PP1 subunit alterations in p21 +/Tert tumors, whereas p21 +/TertCi tumors harbored activating Hras Gln61Lys mutations associated with elevated C > A transversions. Both models exhibited chromosomal aberrations commonly observed in human HCC. Transcriptomic analyses revealed that β-catenin–activated tumors recapitulated gene expression signatures of human HCC, whereas MAPK-mutated tumors showed profiles consistent with MAPK/ERK pathway activation. All HCCs suppressed the gluconeogenic genes Fbp1 and AldoB , but diverged into two distinct groups based on their glycolytic and NRF2 target gene expression profiles. Spatial profiling further revealed reduced HNF4α-positive hepatocytes across tumors, independent of HNF4α transcription, and markedly diminished immune cell infiltration, particularly in β-catenin–activated tumors. Collectively, these findings uncover telomere-independent functions of Tert and identify molecular and metabolic features with potential relevance for predicting immunotherapy response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelomeraseLiver NeoplasmsCarcinogenesisCarcinoma, HepatocellularTelomereAnimalsMiceHumansbeta CateninGene Expression Regulation, NeoplasticTelomere HomeostasisMutationMaleLiverDisease Models, Animal

Substanzen

Telomerasebeta CateninTert protein, mouse

Autor:innen und Institutionen

  • CRCM, Inserm, CNRS, Institut Paoli-Calmettes, Aix-Marseille University Marseille, Équipe labellisée par la Ligue Nationale Contre le Cancer, Marseille, France laura.braud@inserm.fr.
  • CRCM, Inserm, CNRS, Institut Paoli-Calmettes, Aix-Marseille University Marseille, Équipe labellisée par la Ligue Nationale Contre le Cancer, Marseille, France.
  • Predictive Oncology Laboratory, Marseille Cancer Research Centre (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.
  • Centre de recherche des Cordeliers, Sorbonne université, Inserm, Université Paris Cité, Équipe labellisée par la Ligue Nationale Contre le Cancer, Paris, France.
  • AMKbiotech, BIOPARC, Biot, France.
  • Quantimagin, Montpellier, France.

ORCID-Profile: Laura Braud, Julien Vernerey, Dmitri Churikov, Quentin Da Costa, Chantal Desdouets, Vincent Géli

Zitieren

APA

Braud, L., Vernerey, J., Guille, A., Cordier, P., Ginet, C., Egger, T., Bernabe, M., Churikov, D., Da Costa, Q., Meghraoui, A., Desdouets, C., Gu, L., Bertucci, F., Lachaud, C., & Géli, V. (2026). TERT drives liver tumorigenesis beyond telomere elongation. Life Science Alliance, 9(9), e202603660. https://doi.org/10.26508/lsa.202603660

Vancouver

Braud L, Vernerey J, Guille A, Cordier P, Ginet C, Egger T, et al. TERT drives liver tumorigenesis beyond telomere elongation. Life Science Alliance. 2026;9(9):e202603660. doi:10.26508/lsa.202603660

BibTeX
@article{Braud2026,
  author = {Braud, Laura and Vernerey, Julien and Guille, Arnaud and Cordier, Pierre and Ginet, Clémence and Egger, Tom and Bernabe, Manuel and Churikov, Dmitri and Da Costa, Quentin and Meghraoui, Aïda and Desdouets, Chantal and Gu, Li and Bertucci, François and Lachaud, Christophe and Géli, Vincent},
  title = {TERT drives liver tumorigenesis beyond telomere elongation},
  journal = {Life Science Alliance},
  year = {2026},
  volume = {9},
  number = {9},
  pages = {e202603660},
  doi = {10.26508/lsa.202603660}
}
Kostenlos starten →